Protease-activated receptor 1 (PAR1) signalling desensitization is counteracted via PAR4 signalling in human platelets

被引:24
|
作者
Falker, Knut [1 ]
Haglund, Linda [2 ]
Gunnarsson, Peter [2 ]
Nylander, Martina [1 ]
Lindahl, Tomas L. [1 ]
Grenegard, Magnus [2 ]
机构
[1] Linkoping Univ, Fac Med, Div Clin Chem, Dept Clin & Expt Med,Univ Hosp, S-58185 Linkoping, Sweden
[2] Linkoping Univ, Fac Med, Div Drug Res Pharmacol, Dept Med & Hlth Sci,Univ Hosp, S-58185 Linkoping, Sweden
关键词
ADP; desensitization; P2Y(12) receptor; platelet; protease-activated receptor (PAR); protein kinase C (PKC); KINASE-C-BETA; THROMBIN RECEPTOR; SHAPE CHANGE; PATHWAYS; ADP; PHOSPHORYLATION; SPECIFICITY; INHIBITION; PROTEINS; CLEAVAGE;
D O I
10.1042/BJ20101360
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
FARs (protease-activated receptors) 1 and 4 belong to the family of G-protein-coupled receptors which induce both G(alpha 12/13) and G(alpha q) signalling. By applying the specific PAR1- and PAR4-activating hexapeptides, SFLLRN and AYPGKF respectively, we found that aggregation of isolated human platelets mediated via PAR1, but not via PAR4, is abolished upon homologous receptor activation in a concentration- and time-dependent fashion. This effect was not due to receptor internalization, but to a decrease in Ca(2+) mobilization, PKC (protein kinase C) signalling and alpha-granule secretion, as well as to a complete lack of dense granule secretion. Interestingly, subthreshold PAR4 activation rapidly abrogated PAR1 signalling desensitization by differentially reconstituting these affected signalling events and functional responses, which was sufficient to re-establish aggregation. The lack of ADP release and P2Y(12) receptor-induced G(alpha i) signalling accounted for the loss of the aggregation response, as mimicking G(alpha i/z) signalling with 2-MeS-ADP (2-methylthioadenosine-5'-O-diphosphate) or epinephrine (adrenaline) could substitute for intermediate PAR4 activation. Finally, we found that the re-sensitization of PAR1 signalling-induced aggregation via PAR4 relied on PKC-mediated release of both ADP from dense granules and fibrinogen from alpha-granules. The present study elucidates further differences in human platelet PAR signalling regulation and provides evidence for a cross-talk in which PAR4 signalling counteracts mechanisms involved in PAR1 signalling down-regulation.
引用
收藏
页码:469 / 480
页数:12
相关论文
共 50 条
  • [1] Differential effects of quercetin, apigenin and genistein on signalling pathways of protease-activated receptors PAR1 and PAR4 in platelets
    Navarro-Nunez, L.
    Rivera, J.
    Guerrero, J. A.
    Martinez, C.
    Vicente, V.
    Lozano, M. L.
    BRITISH JOURNAL OF PHARMACOLOGY, 2009, 158 (06) : 1548 - 1556
  • [2] Complement factor C4a does not activate protease-activated receptor 1 (PAR1) or PAR4 on human platelets
    Han, Xu
    de la Fuente, Maria
    Nieman, Marvin T.
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2021, 5 (01) : 104 - 110
  • [3] Protease-activated Receptor 1 (PAR1) and PAR4 Heterodimers Are Required for PAR1-enhanced Cleavage of PAR4 by α-Thrombin
    Arachiche, Amal
    Mumaw, Michele M.
    de la Fuente, Maria
    Nieman, Marvin T.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (45) : 32553 - 32562
  • [4] Contributions of Protease-Activated Receptors PAR1 and PAR4 to Thrombin-Induced GPIIbIIIa Activation in Human Platelets
    Duvernay, Matthew T.
    Temple, Kayla J.
    Maeng, Jae G.
    Blobaum, Anna L.
    Stauffer, Shaun R.
    Lindsley, Craig W.
    Hamm, Heidi E.
    MOLECULAR PHARMACOLOGY, 2017, 91 (01) : 39 - 47
  • [5] Protease-activated receptor-1 (PAR1) and PAR2 but not PAR4 mediate relaxations in lower esophageal sphincter
    Huang, Shih-Che
    REGULATORY PEPTIDES, 2007, 142 (1-2) : 37 - 43
  • [6] Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions
    Bilodeau, Matthew L.
    Hamm, Heidi E.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 322 (02): : 778 - 788
  • [7] Protease-Activated Receptor (PAR) 1 and PAR4 Differentially Regulate Factor V Expression from Human Platelets
    Duvernay, Matthew
    Young, Summer
    Gailani, David
    Schoenecker, Jonathan
    Hamm, Heidi
    MOLECULAR PHARMACOLOGY, 2013, 83 (04) : 781 - 792
  • [8] Mapping the Interface Between Protease Activated Receptor 1 (PAR1) and PAR4 Heterodimers.
    Noble, Daniel N.
    de la Fuente, Maria
    Nieman, Marvin T.
    BLOOD, 2010, 116 (21) : 1312 - 1312
  • [9] Protease-activated receptor (PAR)-2 is required for PAR-1 signalling in pulmonary fibrosis
    Lin, Cong
    von der Thusen, Jan
    Daalhuisen, Joost
    ten Brink, Marieke
    Crestani, Bruno
    van der Poll, Tom
    Borensztajn, Keren
    Spek, C. Arnold
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2015, 19 (06) : 1346 - 1356
  • [10] Focal ischemia induces expression of protease-activated receptor1 (PAR1) and PAR3 on microglia and enhances PAR4 labeling in the penumbra
    Henrich-Noack, P
    Riek-Burchardt, M
    Baldauf, K
    Reiser, G
    Reymann, KG
    BRAIN RESEARCH, 2006, 1070 (01) : 232 - 241